Analysts approve of ARB Corp’s two US acquisitions which are expected to build brand awareness and provide medium-term upside
Premier Investments’ pre-announced FY24 sales numbers are below consensus, but brokers await further detail at the full result, along with an update on the company’s strategic review
Accent Group is a tale of recovery and conservative guidance combined with multiple levers to generate upside potential in earnings growth
IPD Group’s FY24 earnings beat management guidance and analysts anticipate upside from organic growth and further M&A activity
Supply Network might be a small cap, but its latest earnings results exemplify a company which ticks so many of the right boxes for investors
A supplier price hike is proving a setback for Macquarie Technology’s cloud services business, but increasing data centre capacity is where the value lays
The New Criterion’s Tim Boreham highlights Arovella Therapeutics in a struggling cell therapies sector worldwide
Australian’s once cozy duopoly for poultry products is breaking down, adding one extra challenge for market leader Inghams Group
Another record year has strengthened analysts’ confidence in the outlook for NRW Holdings, though a weakening iron ore price remains a risk
While the Judo Bank share price rose following FY24 results, some analysts challenge management’s upbeat outlook on asset quality